Zobrazeno 1 - 10
of 12
pro vyhledávání: '"MBC, Metastatic Breast Cancer"'
Autor:
Eleonora De Maio, Gabrielle Selmes, Slimane Zerdoud, Eva Jouve, R. Aziza, Jean-Louis Lacaze, Ciprian Chira, F. Izar, Florence Dalenc, C. Massabeau, Mony Ung, Anne Pradines
Publikováno v:
Breast, Vol 59, Iss, Pp 144-156 (2021)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Does oligometastatic breast cancer (OMBC) deserve a dedicated treatment? Although some authors recommend multidisciplinary management of OMBC with a curative intent, there is no evidence proving this strategy beneficial in the absence of a randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b69d7d75860baca5664d0f6f4d7d4a88
http://www.sciencedirect.com/science/article/pii/S0960977621004069
http://www.sciencedirect.com/science/article/pii/S0960977621004069
Autor:
Tsutomu Iwasa, Tsuyoshi Saito, Kosuke Kashiwabara, Eiko Sakata, Hirofumi Mukai, Masahiro Kitada, Tomohiko Aihara, Naruto Taira, Junji Tsurutani, Yuichiro Kikawa, Tsutomu Takashima, Masato Takahashi, Fumikata Hara, Yoichi Naito, Hiroaki Kato, Yoshie Hasegawa
Publikováno v:
Breast, Vol 55, Iss, Pp 63-68 (2021)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Background Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9e8ab9341270c4ff617be8b94a9f0ec
http://www.sciencedirect.com/science/article/pii/S0960977620302319
http://www.sciencedirect.com/science/article/pii/S0960977620302319
Autor:
Takahiro Kogawa, Ako Hosono, Kenichi Harano, Ayumi Komuro, Yoichi Naito, Chihiro Kondoh, Kanako Mamishin, Shota Kusuhara, Chikako Funasaka, Toru Mukohara, Takehiro Nakao, Mashiro Okunaka, Toshikatsu Kawasaki, Yoko Fukasawa, Nobuaki Matsubara
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 58, Iss, Pp 50-56 (2021)
Breast, Vol 58, Iss, Pp 50-56 (2021)
Background Visceral crisis in metastatic breast cancer (MBC) is defined as severe organ dysfunction requiring rapidly efficacious therapy. Although weekly paclitaxel plus bevacizumab (wPTX + BV) achieves a high response rate in human epidermal growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceeb2f8c28b19a71d25194b192d9cf8f
https://pubmed.ncbi.nlm.nih.gov/33901922
https://pubmed.ncbi.nlm.nih.gov/33901922
Publikováno v:
JAAD Case Reports
Breast cancer is the second most common malignancy after melanoma to metastasize to skin.1 Approximately 30% of individuals with metastatic breast cancer (MBC) go on to have cutaneous metastases, frequently presenting as firm nodules, diffuse infiltr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3316cab49b2a233fb34948de2f0039a
https://doi.org/10.1016/j.jdcr.2018.04.013
https://doi.org/10.1016/j.jdcr.2018.04.013
Autor:
Quchang Ouyang, Xin Yi, Xiaohong Yang, Jianxiang Gao, Zheyu Hu, Xuming Hu, Can Tian, Lianpeng Chang, Xuefeng Xia, Yu Tang, Qianjin Liao, Mengjia Xiao, Qiongzhi He, Liping Liu, Hui Wu, Jing Li, Jun Lu, Ning Xie, Huawu Xiao, Min Cao, Zhengrong Shui
Publikováno v:
EBioMedicine
EBioMedicine, Vol 32, Iss, Pp 111-118 (2018)
EBioMedicine, Vol 32, Iss, Pp 111-118 (2018)
Purpose In cancer patients, tumor gene mutations contribute to drug resistance and treatment failure. In patients with metastatic breast cancer (MBC), these mutations increase after multiline treatment, thereby decreasing treatment efficiency. The ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09ba2a916d616434f8644bf3d44cb54d
http://europepmc.org/articles/PMC6020712
http://europepmc.org/articles/PMC6020712
Autor:
Yuzuru Yamazoe, Maki Tanioka, Kazuhiko Nakagawa, Masashi Yanae, Junji Tsurutani, Kaori Tane, Yoshiyuki Morishima, Shin-ichiro Fujimoto, Kimiko Fujiwara, Shozo Nishida, Yasutaka Chiba, Shintaro Takao, Masanobu Tsubaki, Yoshifumi Komoike
Publikováno v:
Journal of Bone Oncology, Vol 8, Iss C, Pp 18-22 (2017)
Journal of Bone Oncology
Journal of Bone Oncology
Background: Bone represents one of the most common sites to which breast cancer cells metastasize. Patients experience skeletal related adverse events (pathological fractures, spinal cord compressions, and irradiation for deteriorated pain on bone) e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f66a1bac20cfb6606a9e4ddb03d2fc3
http://www.sciencedirect.com/science/article/pii/S2212137417300647
http://www.sciencedirect.com/science/article/pii/S2212137417300647
Autor:
Mihaela Palade Gheran, Patricia Calloud de Faudeur, Eti Kimhi, Claudia Altmann-Pospischek, Sabine Spitz, Renate Haidinger, Donatella Decise, Fatima Cardoso, Mona Elzayat, Ana Casas
Publikováno v:
The Breast : official journal of the European Society of Mastology
Breast, Vol 49, Iss, Pp 171-173 (2020)
Breast, Vol 49, Iss, Pp 171-173 (2020)
Many ABC/MBC (advanced or metastatic breast cancer) patients describe feelings of isolation and lack of support [1], often exacerbated by inadequate and insensitive communication. To examine these issues and the changing landscape of the wider breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::566342df5d5541b4f86b1cfa4d546c81
https://hdl.handle.net/10668/14802
https://hdl.handle.net/10668/14802
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Breast cancers that are positive for human epidermal growth factor receptor 2 (HER2) are aggressive and typically associated with a poor prognosis. • Novel anti-HER2 therapies have recently improved the outcomes in these cases. • W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d575b4fb05261fdd1807011f600c8598
https://pubmed.ncbi.nlm.nih.gov/30343261
https://pubmed.ncbi.nlm.nih.gov/30343261
Autor:
John W.M. Martens, Wendy Onstenk, Jaco Kraan, John A. Foekens, Caroline M. Seynaeve, Paul Hamberg, Anja Brouwer, Stefan Sleijfer, Ngoc M. Van, Agnes Jager, Felix E. de Jongh, Anieta M. Sieuwerts, Nick Beije, Luc Dirix
Publikováno v:
Neoplasia, 18(11), 647-653. Neoplasia Press
Neoplasia (New York, N.Y.)
Neoplasia: An International Journal for Oncology Research, Vol 18, Iss 11, Pp 647-653 (2016)
Neoplasia (New York, N.Y.)
Neoplasia: An International Journal for Oncology Research, Vol 18, Iss 11, Pp 647-653 (2016)
BACKGROUND: Preclinical and clinical studies have reported that human epidermal growth factor receptor 2 (HER2) overexpression yields resistance to endocrine therapies. Here the prevalence and prognostic impact of HER2-positive circulating tumor cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d4fbb5219b9c6cf6089a65ce61d0c78
https://pure.eur.nl/en/publications/8edc9b57-5cb4-4e3c-8a17-9a2de6d48010
https://pure.eur.nl/en/publications/8edc9b57-5cb4-4e3c-8a17-9a2de6d48010
Autor:
Krishnasamy SR; Department of Internal Medicine, Rutgers New Jersey Medical School, New Brunswick, New Jersey.; Department of Dermatology, City of Hope National Comprehensive Cancer Center, Los Angeles, California., Almazan TH; Department of Dermatology, Stanford University School of Medicine Stanford, Los Angeles.; Department of Dermatology, City of Hope National Comprehensive Cancer Center, Los Angeles, California., Suero-Abreu GA; Department of Internal Medicine, Rutgers New Jersey Medical School, New Brunswick, New Jersey., Jung JY; Department of Dermatology, City of Hope National Comprehensive Cancer Center, Los Angeles, California.; Department of Dermatology, University of Louisville, Louisville, Kentucky.
Publikováno v:
JAAD case reports [JAAD Case Rep] 2018 Aug 15; Vol. 4 (7), pp. 711-715. Date of Electronic Publication: 2018 Aug 15 (Print Publication: 2018).